Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.

This publication has 39 references indexed in Scilit:

• The LDL-receptor-related protein ??? portrait of a multifunctional receptor
  Current Opinion in Lipidology, 1993
• Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
  Science, 1992
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
  Published by Elsevier ,1992
• The role of apolipoprotein E genetic variants in lipoprotein disorders
  Journal of Internal Medicine, 1992
• Role of apolipoprotein E in hepatic lipase-catalyzed hydrolysis of phospholipid in high-density lipoproteins
  Biochemistry, 1992
• Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.
  Journal of Clinical Investigation, 1991
• Chylomicron and chylomicron remnant catabolism
  Current Opinion in Lipidology, 1991
• Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
• Distinctive populations of basement membrane and cell membrane heparan sulfate proteoglycans are produced by cultured cell lines.
  The Journal of cell biology, 1987
• The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972